User profiles for Romina Brignardello-Petersen

Romina Brignardello-Petersen

Associate Professor, Department of Health Research Methods, Evidence, and Impact; …
Verified email at mcmaster.ca
Cited by 21245

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision

…, S Bosnic-Anticevich, R Brignardello-Petersen… - Journal of Allergy and …, 2017 - Elsevier
Background Allergic rhinitis (AR) affects 10% to 40% of the population. It reduces quality of
life and school and work performance and is a frequent reason for office visits in general …

Drug treatments for covid-19: living systematic review and network meta-analysis

…, L Yao, Y Zhao, GH Guyatt, R Brignardello-Petersen - bmj, 2020 - bmj.com
Objective To compare the effects of treatments for coronavirus disease 2019 (covid-19).
Design Living systematic review and network meta-analysis. Data sources WHO covid-19 …

2020 American College of Rheumatology guideline for the management of gout

…, T Mikuls, R BrignardelloPetersen… - Arthritis & …, 2020 - Wiley Online Library
Objective To provide guidance for the management of gout, including indications for and
optimal use of urate‐lowering therapy ( ULT ), treatment of gout flares, and lifestyle and other …

GRADE Evidence to Decision (EtD) frameworks: a systematic and transparent approach to making well informed healthcare choices. 1: Introduction

…, HJ Schünemann, J Moberg, R Brignardello-Petersen… - bmj, 2016 - bmj.com
Healthcare decision making is complex. Decision-making processes and the factors (criteria)
that decision makers should consider vary for different types of decisions, including clinical …

A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis

…, MH Murad, T Li, R Brignardello-Petersen… - Bmj, 2014 - bmj.com
Network meta-analysis (NMA), combining direct and indirect comparisons, is increasingly
being used to examine the comparative effectiveness of medical interventions. Minimal …

A living WHO guideline on drugs for covid-19

…, JJ Bartoszko, L Ge, R Brignardello-Petersen… - 2022 - scholar.sun.ac.za
This living guideline by Arnav Agarwal and colleagues (BMJ 2020; 370: m3379, doi: 10.1136/bmj.
m3379) was last updated on 22 April 2022, but the infographic contained two dosing …

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

…, I Bou Akl, M Boulos, R Brignardello-Petersen… - Blood …, 2021 - ashpublications.org
Background: Coronavirus disease 2019 (COVID-19)–related critical illness and acute illness
are associated with a risk of venous thromboembolism (VTE). Objective: These evidence-…

A living WHO guideline on drugs for covid-19

…, JJ Bartoszko, L Ge, R Brignardello-Petersen… - bmj, 2020 - bmj.com
Updates This is the fourteenth version (thirteenth update) of the living guideline, replacing
earlier versions (available as data supplements). New recommendations will be published as …

Guidelines 2.0: systematic development of a comprehensive checklist for a successful guideline enterprise

…, R Mustafa, M Ventresca, R Brignardello-Petersen… - Cmaj, 2014 - Can Med Assoc
Background: Although several tools to evaluate the credibility of health care guidelines exist,
guidance on practical steps for developing guidelines is lacking. We systematically …

[HTML][HTML] GRADE guidelines 26: informative statements to communicate the findings of systematic reviews of interventions

…, EA Akl, B Alper, R Brignardello-Petersen… - Journal of clinical …, 2020 - Elsevier
Objectives Clear communication of systematic review findings will help readers and decision
makers. We built on previous work to develop an approach that improves the clarity of …